AACR Project GENIE: Powering Precision Medicine through an International Consortium
2017 · Cancer Discovery · 1,930 citations
https://doi.org/10.1158/2159-8290.cd-17-0151
L
Lillian L. Siu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.3K
Papers
40.7K
Citations
101
h-index
411
i10-index
Lillian L. Siu is an academic researcher from University Health Network. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations. The author has an h-index of 101, co-authored 1088 publications.
ORCID: 0000-0002-3500-0540Papers by this author
worksMolecular profiling for precision cancer therapies
2020 · Genome Medicine · 853 citations
https://doi.org/10.1186/s13073-019-0703-1
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
2006 · British Journal of Cancer · 316 citations
https://doi.org/10.1038/sj.bjc.6603419
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
2016 · Genome Medicine · 275 citations
https://doi.org/10.1186/s13073-016-0364-2
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
2018 · European Journal of Cancer · 262 citations
https://doi.org/10.1016/j.ejca.2018.11.015
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors
2014 · Journal of Hematology & Oncology · 189 citations
https://doi.org/10.1186/1756-8722-7-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat